Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03124186Not ApplicableCompleted

Sensory-driven Motor Recovery in Poorly Recovered Subacute Stroke Patients

Role: lead

NCT02788357Phase 2Completed

Post-stroke Neural Plasticity With Atomoxetine

Role: lead

NCT02633215Not ApplicableCompleted

Enhancing Plasticity in Stroke Patients With Severe Motor Deficit

Role: lead

NCT03124147Not ApplicableCompleted

Optimizing Transcranial Direct Current Stimulation for Motor Recovery From Hemiparesis

Role: lead

NCT02850042Phase 2Completed

Comparing Constraint-Induced Therapy and Occupation-Based Intervention for Optimal Stroke Recovery

Role: lead

All 5 trials loaded